February 5, 2008Open Access

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Patients with TNBC have increased pCR rates compared with non-TNBC, and those with pCR have excellent survival. However, patients with RD after neoadjuvant chemotherapy have significantly worse survival if they have TNBC compared with non-TNBC, particularly in the first 3 years.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Cornelia Liedtke

Chafika Mazouni

Kenneth R. Hess

Journals

Journal of Clinical Oncology

Actions

Institutions

The University of Texas MD Anderson Cancer Center

Institut Gustave Roussy

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study